UK markets open in 2 hours 41 minutes

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.05+0.34 (+2.03%)
At close: 04:00PM EDT
17.05 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-61,286
-61,286
-215,975
-167,870
-281,584
Depreciation & amortisation
5,552
5,552
2,026
3,344
2,932
Stock-based compensation
66,421
66,421
68,201
63,615
84,422
Change in working capital
18,133
18,133
37,991
-24,824
11,036
Accounts receivable
-36,072
-36,072
2,171
-16,119
-12,466
Inventory
-28,808
-28,808
2,415
-4,210
-3,320
Accounts payable
4,797
4,797
5,870
-1,617
1,271
Other working capital
-23,348
-23,348
-114,035
-126,782
-143,753
Other non-cash items
-
-
-
-
44,280
Net cash provided by operating activities
16,702
16,702
-114,035
-125,660
-136,166
Cash flows from investing activities
Investments in property, plant and equipment
-40,050
-40,050
-
-1,122
-7,587
Purchases of investments
-369,985
-369,985
-363,174
-492,797
-339,908
Sales/maturities of investments
442,033
442,033
436,415
422,817
540,004
Net cash used for investing activities
31,998
31,998
73,241
-71,102
192,509
Cash flows from financing activities
Common stock issued
25,129
25,129
8,199
18,162
80,996
Net cash used provided by (used for) financing activities
25,129
25,129
8,199
18,162
80,996
Net change in cash
73,811
73,811
-32,589
-178,593
137,331
Cash at beginning of period
120,616
120,616
153,205
331,798
194,467
Cash at end of period
194,427
194,427
120,616
153,205
331,798
Free cash flow
Operating cash flow
16,702
16,702
-114,035
-125,660
-136,166
Capital expenditure
-40,050
-40,050
-
-1,122
-7,587
Free cash flow
-23,348
-23,348
-114,035
-126,782
-143,753